Distinguished Scientist
Genentech, Inc.
South San Francisco, California
Sandhya Mandlekar is an expert in small molecule pharmacokinetics (PK), pharmacodynamics (PD) and drug disposition, with 20+ years
of experience co-leading drug optimization teams through clinical candidate nomination. She has over ten years of experience in building, mentoring, and directing multi-disciplinary non-clinical PKDM, bioanalytical, investigative toxicology teams. More recently, she also acquired over five years of experience as a global clinical pharmacology lead on small molecule oncology projects. She is experienced in oncology dose optimization, clinical pharmacology strategy and execution, regulatory interactions with global health authorities throughout IND and EOP2 stages of drug development.
Disclosure information not submitted.
Novel Oral Molecules: Preclinical to Clinical Translation of Absorption-Disposition
Tuesday, November 11, 2025
3:30 PM - 3:45 PM CT